2022 annual financial data
Aquestive Therapeutics 2022 Operating margin
Direct answer
Operating margin was -88.23%.
Operating income was -42,066,000 USD and net income was -54,410,000 USD.
Operating cash flow was -9,789,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,680,000 USD
- Operating income
- -42,066,000 USD
- Net income
- -54,410,000 USD
- Operating cash flow
- -9,789,000 USD